Article Text

Download PDFPDF

Correction: Metformin limits osteoarthritis development and progression through activation of AMPK signalling
Free

Statistics from Altmetric.com

Li J, Zhang B, Liu W, et al. Metformin limits osteoarthritis development and progression through activation of AMPK signalling. Ann of Rheum Dis 2020;79:635–45. doi:10.1136/annrheumdis-2019-216713.

The following funding information was missed from the final version:

This work was supported by the National Institutes of Health (NIH) Grant R01AR070222 to DC. This work was also partially supported by grants from the National Nature Science Foundation of China (NSFC) (81620108018, 81930070), and Tianjin key research and development plan, key projects for science and technology support (19YFZCSY00660) to SF. This work was also partially supported by NSFC grants (81874011, 81 572 104 and 81301531) to TW. This work was also supported by the NSFC grant (81672227) and the Frontier Science of CAS grant (QYZDB-SSW-JSC030) to HP.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles